Derek J Maetzold

CIK 1239501 · Pres. & Chief Exec. Officer · last filed 2026-11-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$4.98M
Companies
2
Total Filings
236
Lifetime Open-Market Net
-$97.41M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CSTL price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
820 S. FRIENDSWOOD DRIVE
SUITE 201
FRIENDSWOOD, TX 77546
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CSTL Pres. & Chief Exec. Officer 149,000 $33.41 $4.98M -$97.41M 199 2026-11-18
ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted V.P., Marketing & Sales 0 — — $0 4 2008-04-03

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
CSTL Direct 0 0.0% 2026-11-18
By DJM Grantor Retained Annuity Trust No. 8 40,935 27.5% 2026-11-18
By DJM Grantor Retained Annuity Trust No. 7 27,862 18.7% 2026-11-18
DJM Grantor Retained Annuity Trust No. 9 23,216 15.6% 2026-11-18
By DJM Grantor Retained Annuity Trust No. 6 11,963 8.0% 2026-11-18
By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold 11,256 7.6% 2026-11-18
By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold 11,256 7.6% 2026-11-18
By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold 11,256 7.6% 2026-11-18
By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk 11,256 7.6% 2026-11-18
By The Maetzold Descendants 2020 Trust 0 0.0% 2026-11-18
By Derek Maetzold 2020 Irrevocable Trust 0 0.0% 2026-11-18
Total 149,000
No longer reported
By DJM Grantor Retained Annuity Trust No. 5 85,959 — last 2026-06-03
By DJM Grantor Retained Annuity Trust No. 4 130,000 — last 2023-05-17
By DJM Grantor Retained Annuity Trust No. 3 75,000 — last 2022-04-28
By DJM Grantor Retained Annuity Trust No. 2 55,603 — last 2022-04-28
By DJM Grantor Retained Annuity Trust No. 1 0 — last 2022-01-20

10b5-1 Trading Plans

6 plans · 1 in force
Plans this person adopted or ended, as the company reported them in its 10-Q or 10-K. A Rule 10b5-1 plan sets trades in advance; a director's or officer's plan can't sell until a cooling-off period ends, 90 to 120 days after adoption. Sold so far adds up the open-market sales filed on Form 4 under a plan since it was adopted, and the percentage is of the shares the plan allows.
Company Adopted Sales Can Start Ends Plan Allows Sold So Far Status Link
CSTL
Chief Executive Officer
Jun 2, 2026 Aug 31, 2026 Mar 19, 2027 383,425 shares 79,444 (21%)
last filed Nov 18, 2026
Active 10-Q
CSTL
Chief Executive Officer
Dec 3, 2025 Mar 3, 2026 Aug 31, 2026 374,116 shares 257,698 (69%)
last filed Sep 1, 2026
Ended 10-K
CSTL
Chief Executive Officer
May 8, 2025 Aug 6, 2025 Feb 13, 2026 97,123 shares 77,872 (80%)
last filed Feb 5, 2026
Ended 10-Q
CSTL
Chief Executive Officer
Nov 11, 2024 Mar 3, 2025 Aug 13, 2025 301,404 shares 117,391 (39%)
last filed Aug 15, 2025
Ended 10-K
CSTL
Chief Executive Officer
May 24, 2024 Aug 22, 2024 Feb 21, 2025 92,395 shares 81,705 (88%)
last filed Jan 15, 2025
Ended 10-Q
CSTL
Chief Executive Officer
Dec 5, 2023 Mar 4, 2024 Jun 5, 2024 228,103 shares 44,384 (19%)
last filed Jun 5, 2024
Ended 10-K
Sales can start: the later of 90 days after adoption and two business days after the report for the quarter it was adopted in, capped at 120 days. Ends: the end date the company gave, or adoption plus the plan's stated length; a plan can also end sooner once its shares are sold. Ended early means the company reported the plan terminated before that date. Sold so far is left blank while a plan is cooling off, and when a stock split falls inside the plan the percentage is left out because the limit is in pre-split shares.

Recent Filings · Page 14 of 24

236 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2023-04-05 CSTL Sell (S)10b5-1
Plan adopted Dec 12, 2022
−8,372 -$185.4K EDGAR
2023-03-16 CSTL Sell (S) −8,372 -$175.4K EDGAR
2023-03-08 CSTL Sell (S) −8,372 -$206.9K EDGAR
2023-02-14 CSTL Sell (S) −8,372 -$219.2K EDGAR
2023-02-03 CSTL Sell (S) −8,384 -$227.3K EDGAR
2023-01-05 CSTL Sell (S) −8,958 -$205.1K EDGAR
2022-12-21 CSTL Sell (S) −8,958 -$206.7K EDGAR
2022-12-13 CSTL Mixed +14,472 -$141.0K EDGAR
2022-12-07 CSTL Sell (S) −8,958 -$222.1K EDGAR
2022-12-05 CSTL Exer (M) +10,000 $37.2K EDGAR
Showing 131–140 of 236
Page 14 of 24
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).